25
Participants
Start Date
January 1, 2025
Primary Completion Date
June 1, 2029
Study Completion Date
June 1, 2029
Brivaracetam
"* Intravenous administration: 25 mg or 50 mg will be administered depending on its effects on epileptic activity during a hospital stay where simultaneous EEG and depth electrode recordings will be measuring epileptic activity.~* Oral administration: Subjects will take 25mg or 50mg twice a day for 12 months. The dosage will depend on its effects on epileptic activity. Brivaracetam levels will be measured on months 3, 6 and 12."
Mary S. Easton Center for Alzheimer's Research and Care, Los Angeles
University of California, Los Angeles
OTHER